[1] 钱波,万圣云,喻宗繁,等.原发性肝癌手术预后影响因素分析.安徽医科大学学报,2015,24:1479-1482.
[2] Simsek G. Hepatocellular carcinoma recurring in the opposite lobe nine years after regular right hepatectomy. Eur J Gen Med,2015,4:278-281.
[3] 王润之. 原发性肝癌规则性肝切除和非规则性肝切除的手术适应证分析. 肝脏,2016, 2:114-116.
[4] 丛文铭,步宏,陈杰,等. 原发性肝癌规范化病理诊断指南(2015年版). 临床肝胆病杂志,2015, 6:833-839.
[5] 汤钊猷,杨秉辉. 原发性肝癌的研究与进展. 西南师范大学出版社, 1990:35.
[6] Malki A,El-Sharkawy A,El Syaed M, et al. Antitumor activities of the novel isosteviol derivative 10C against liver cancer. Anticancer Res, 2017,4:1591.
[7] 林泽毅,朱少亮,黄山,等. 单发小肝癌规则切除与非规则切除疗效及其预后因素分析. 中华肿瘤防治杂志,2015,14:1128-1133.
[8] 张军,许建伟,殷凯,等.肝癌肝部分切除术后患者血小板计数与肝功能恢复的相关性研究.肝胆胰外科杂志,2012,33:359-361.
[9] 杨可立,陈敏山,陈锦滨.小肝癌多学科综合治疗方式优化选择.中国实用外科杂志,2016,14:623-627.
[10] Shimizu A,Kobayashi A,Yokoyama T,et al. Correlation between the serum levels of type IV collagen 7s domain and the risk of intractable ascites following liver resection for hepatocellular carcinoma: a propensity score-matched analysis. Surgery, 2016, 5:1244-1255. |
